Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome is a cluster of three or more metabolic disorders including insulin resistance, obesity, and hyperlipidemia. Obesity has become the epidemic of the twenty-first century with more than 1.6 billion overweight adults. Due to the strong connection between obesity and type 2 diabetes, obesity has received wide attention with subsequent coining of the term "diabesity." Recent studies have identified unique contributions of the immensely diverse gut microbiota in the pathogenesis of obesity and diabetes. Several mechanisms have been proposed including altered glucose and fatty acid metabolism, hepatic fatty acid storage, and modulation of glucagon-like peptide (GLP)-1. Importantly, the relationship between unhealthy diet and a modified gut microbiota composition observed in diabetic or obese subjects has been recognized. Similarly, the role of diet rich in polyphenols and plant polysaccharides in modulating gut bacteria and its impact on diabetes and obesity have been the subject of investigation by several research groups. Gut microbiota are also responsible for the extensive metabolism of polyphenols thus modulating their biological activities. The aim of this review is to shed light on the composition of gut microbes, their health importance and how they can contribute to diseases as well as their modulation by polyphenols and polysaccharides to control obesity and diabetes. In addition, the role of microbiota in improving the oral bioavailability of polyphenols and hence in shaping their antidiabetic and antiobesity activities will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889 · cited 16×
“Fu’s team identified 34 bacterial taxa that were associated with obesity, triglyceride and HDL levels in their study group.”
BackgroundInfluentialRetractedTowards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya.
Woese, C. R., Kandler, O., & Wheelis, M. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4576 · Cited by 6,128 · cited 2×
“Historically, archaea were classified as bacteria with the name (archaebacteria) before being reclassified in a specific domain (Woese et al., 1990; Pace, 2006), since they have characteristic features unique enough to separate them from bacteria and Eukaryota domains (Cavicchioli, 2011).”
BackgroundGut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 1×
“Differences in the composition of the gut microbiota in humans that relate to disease have been reported for several conditions including, but not limited to, cardiovascular disease (Holmes et al., 2008; Wang et al., 2011), type 2 diabetes (Larsen et al., 2010), and obesity (Turnbaugh et al., 2009).”
BackgroundDiversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Proteobacteria: Microbial signature of dysbiosis in gut microbiota
Shin, N.-R., Whon, T. W., & Bae, J.-W. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.06.011 · Cited by 3,954 · cited 4×
“Members of the phylum Proteobacteria, mostly belonging to γ -proteobacteria, have a low abundance in the gut of healthy humans (Shin et al., 2015).”
BackgroundInfluentialIntestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“…more genes than the human genome and functional redundancy among some of these genes allow different microbes to create individualized communities that will carry out the same functions to maintain homeostasis and a symbiotic relationship with the human host (Ley et al., 2006; Qin et al., 2010).”
BackgroundDynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.004 · Cited by 3,315
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164 · cited 2×
“Although, studies generally suggest that genetic effects do not exert a strong global influence on which microbes colonize the gut, monozygotic twin pairs display more similar microbiota than their dizygotic counterparts (Turnbaugh et al., 2009; Smith et al., 2013; Goodrich et al., 2014).”
BackgroundDietary polyphenols and the prevention of diseases
Scalbert, A., Manach, C., Morand, C., Rémésy, C., & Jiménez, L. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040869059096 · Cited by 2,999
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · cited 2×
“Differences in the composition of the gut microbiota in humans that relate to disease have been reported for several conditions including, but not limited to, cardiovascular disease (Holmes et al., 2008; Wang et al., 2011), type 2 diabetes (Larsen et al., 2010), and obesity (Turnbaugh et al., 2009).”
BackgroundVrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
The gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791
Succession of microbial consortia in the developing infant gut microbiome
Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., Angenent, L. T., & Ley, R. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000081107 · Cited by 2,540 · cited 3×
“For infants who are breastfed, the discontinuation of breastfeeding appears to be the strongest factor driving the change in gut microbiota structure from the less diverse infant microbiome to the more diverse adult phenotype (Koenig et al., 2011; Bäckhed et al., 2015).”
BackgroundCani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 3×
“In addition, higher levels of A . muciniphila were associated with greater enteroendocrine L-cell activity, hence more secretion of glucagon-like peptides GLP-1 and GLP-2 (Cani et al., 2009).”
BackgroundChemistry and biochemistry of dietary polyphenols
Tsao, R. (2010) · Nutrients · doi:10.3390/nu2121231 · Cited by 2,415 · cited 3×
“They predominantly exist in combination with sugars or acylated sugars (glycosides), but may also occur in other conjugated structures (amides, esters, and methyl ethers) or in their free forms (Tsao, 2010).”
BackgroundAkkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 2×
“In 2004, Akkermansia muciniphila a novel mucin-degrading bacterium was also identified from a healthy human volunteer using 16S rRNA-dependent approaches (Derrien et al., 2004).”
BackgroundGenomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Lloyd-Price, J., Abu-Ali, G., & Huttenhower, C. (2016) · Genome Medicine · doi:10.1186/s13073-016-0307-y · Cited by 1,891 · cited 1×
“Healthy human gut microbiota includes archaea, fungi, and viruses as consistent residents (Parfrey et al., 2011; Lloyd-Price et al., 2016; Rehman et al., 2016), even though in some cases at low densities.”
BackgroundDysbiosis of the gut microbiota in disease
Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., & Owen, L. J. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26191 · Cited by 1,710 · cited 1×
“It has been associated with many chronic diseases including metabolic disorders such as obesity and type 2 diabetes (Carding et al., 2015).”
BackgroundNauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
Bacteria as vitamin suppliers to their host: A gut microbiota perspective
LeBlanc, J. G., Milani, C., de Giori, G. S., Sesma, F., van Sinderen, D., & Ventura, M. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.08.005 · Cited by 1,613 · cited 2×
“…with essential metabolites such as vitamin K, thiamine, biotin, folic acid, and vitamin B12, digesting polysaccharides into simpler molecules, boosting the immunity to combat pathogens, and competing with the latter for survival (Santacruz et al., 2010; D’Aimmo et al., 2012; LeBlanc et al., 2013).”
BackgroundBrown adipose tissue activity controls triglyceride clearance
Bartelt, A., Bruns, O. T., Reimer, R., Hohenberg, H., Ittrich, H., Peldschus, K., Kaul, M. G., Tromsdorf, U. I., Weller, H., Waurisch, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2297 · Cited by 1,608 · cited 1×
“When stimulated, FFA are used-up to clear the TGs (Bartelt et al., 2011) in turn regulating glucose homeostasis (Stanford et al., 2013) (Peirce and Vidal-Puig, 2013).”
MethodA Genomic View of the Human- Bacteroides thetaiotaomicron Symbiosis
Xu, J., Bjursell, M. K., Himrod, J., Deng, S., Carmichael, L. K., Chiang, H. C., Hooper, L. V., & Gordon, J. I. (2003) · Science · doi:10.1126/science.1080029 · Cited by 1,353 · cited 1×
“…is colonized by higher numbers of bacteria and more diverse species compared to other parts of the body and Holdeman, 1974; Holdeman et al., 1976; Xu et al., 2003 Bacteroides fragilis Moore and Holdeman, 1974; Holdeman et al., 1976 Bacteroides clostridiiformis Moore and Holdeman, 1974; Hayashi…”
BackgroundInteraction between Phenolics and Gut Microbiota: Role in Human Health
Selma, M. V., Espín, J. C., & Tomás-Barberán, F. A. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf902107d · Cited by 1,324
Measurement of gastrointestinal pH profiles in normal ambulant human subjects
Evans, D. F., Pye, G., Bramley, R., Clark, A. G., Dyson, T. J., & Hardcastle, J. D. (1988) · Gut · doi:10.1136/gut.29.8.1035 · Cited by 1,240
Human oral, gut, and plaque microbiota in patients with atherosclerosis
Koren, O., Spor, A., Felin, J., Fåk, F., Stombaugh, J., Tremaroli, V., Behre, C. J., Knight, R., Fagerberg, B., Ley, R. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011383107 · Cited by 1,196
The first 1000 cultured species of the human gastrointestinal microbiota
Rajilić-Stojanović, M., & de Vos, W. M. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12075 · Cited by 1,182
Brown adipose tissue regulates glucose homeostasis and insulin sensitivity
Stanford, K. I., Middelbeek, R. J. W., Townsend, K. L., An, D., Nygaard, E. B., Hitchcox, K. M., Markan, K. R., Nakano, K., Hirshman, M. F., Tseng, Y.-H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62308 · Cited by 1,180 · cited 1×
“When stimulated, FFA are used-up to clear the TGs (Bartelt et al., 2011) in turn regulating glucose homeostasis (Stanford et al., 2013) (Peirce and Vidal-Puig, 2013).”
MethodGut Microbiomes of Malawian Twin Pairs Discordant for Kwashiorkor
Smith, M. I., Yatsunenko, T., Manary, M. J., Trehan, I., Mkakosya, R., Cheng, J., Kau, A. L., Rich, S. S., Concannon, P., Mychaleckyj, J. C., et al. (2013) · Science · doi:10.1126/science.1229000 · Cited by 1,173 · cited 1×
“Although, studies generally suggest that genetic effects do not exert a strong global influence on which microbes colonize the gut, monozygotic twin pairs display more similar microbiota than their dizygotic counterparts (Turnbaugh et al., 2009; Smith et al., 2013; Goodrich et al., 2014).”
BackgroundHuman Fecal Flora: The Normal Flora of 20 Japanese-Hawaiians
Moore, W. E. C., & Holdeman, L. V. (1974) · Applied Microbiology · doi:10.1128/am.27.5.961-979.1974 · Cited by 1,144
Anhê, F. F., Roy, D., Pilon, G., Dudonné, S., Matamoros, S., Varin, T. V., Garofalo, C., Moine, Q., Desjardins, Y., Levy, E., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307142 · Cited by 1,137
Diet dominates host genotype in shaping the murine gut microbiota
Carmody, R. N., Gerber, G. K., Luevano, J. M., Gatti, D. M., Somes, L., Svenson, K. L., & Turnbaugh, P. J. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.010 · Cited by 1,103 · cited 1×
“However, two recent studies reported increased levels of A. muciniphila in animals fed with high fat and high carbohydrate diet (Carmody et al., 2015; Hamilton et al., 2015).”
BackgroundHooper, L., Kroon, P. A., Rimm, E. B., Cohn, J. S., Harvey, I., Le Cornu, K. A., Ryder, J. J., Hall, W. L., & Cassidy, A. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.1.38 · Cited by 1,097
Human metabolic phenotype diversity and its association with diet and blood pressure
Holmes, E., Loo, R. L., Stamler, J., Bictash, M., Yap, I. K. S., Chan, Q., Ebbels, T., De Iorio, M., Brown, I. J., Veselkov, K. A., et al. (2008) · Nature · doi:10.1038/nature06882 · Cited by 1,054 · cited 1×
“Differences in the composition of the gut microbiota in humans that relate to disease have been reported for several conditions including, but not limited to, cardiovascular disease (Holmes et al., 2008; Wang et al., 2011), type 2 diabetes (Larsen et al., 2010), and obesity (Turnbaugh et al., 2009).”
BackgroundThe human gut virome: inter-individual variation and dynamic response to diet
Minot, S., Sinha, R., Chen, J., Li, H., Keilbaugh, S. A., Wu, G. D., Lewis, J. D., & Bushman, F. D. (2011) · Genome Research · doi:10.1101/gr.122705.111 · Cited by 935 · cited 2×
“Each individual holds a unique viral profile, highlighting the high interpersonal variability of the healthy human gut virome (Minot et al., 2011; Scarpellini et al., 2015).”
BackgroundDe Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D. I., Cristofori, F., Guerzoni, M. E., Gobbetti, M., & Francavilla, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076993 · Cited by 887 · cited 1×
“They have received much attention in recent year because their density is reported to increase in inflammatory bowel diseases and in children suffering from autism and down-syndrome (De Angelis et al., 2013; Hiippala et al., 2016).”
BackgroundSantacruz, A., Collado, M. C., García-Valdés, L., Segura, M. T., Martín-Lagos, J. A., Anjos, T., Martí-Romero, M., Lopez, R. M., Florido, J., Campoy, C., et al. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510000176 · Cited by 868
Microbiota and diabetes: an evolving relationship
Tilg, H., & Moschen, A. R. (2014) · Gut · doi:10.1136/gutjnl-2014-306928 · Cited by 853 · cited 3×
“A. muciniphila levels were found to be inversely associated to obesity and diabetes in several animal and human studies (Tilg and Moschen, 2014).”
BackgroundResultInfluentialMeta‐analyses of human gut microbes associated with obesity and IBD
Walters, W. A., Xu, Z., & Knight, R. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.09.039 · Cited by 836
Ramirez-Farias, C., Slezak, K., Fuller, Z., Duncan, A., Holtrop, G., & Louis, P. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508019880 · Cited by 822
Schneeberger, M., Everard, A., Gómez-Valadés, A. G., Matamoros, S., Ramírez, S., Delzenne, N. M., Gomis, R., Claret, M., & Cani, P. D. (2015) · Scientific Reports · doi:10.1038/srep16643 · Cited by 798 · cited 5×
“muciniphila is a Gram-negative bacterium that resides in the mucus layer and constitutes 3–5% of gut microbiota and is thus considered to be the most abundant mucus-degrading bacteria in healthy humans (Schneeberger et al., 2015).”
BackgroundInfluentialThe Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
Fu, J., Bonder, M. J., Cenit, M. C., Tigchelaar, E. F., Maatman, A., Dekens, J. A. M., Brandsma, E., Marczynska, J., Imhann, F., Weersma, R. K., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306807 · Cited by 748
Intestinal microbiota in human health and disease: the impact of probiotics
Gerritsen, J., Smidt, H., Rijkers, G. T., & de Vos, W. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0229-7 · Cited by 724
Zoetendal, E. G., Raes, J., van den Bogert, B., Arumugam, M., Booijink, C. C. G. M., Troost, F. J., Bork, P., Wels, M., de Vos, W. M., & Kleerebezem, M. (2012) · The ISME Journal · doi:10.1038/ismej.2011.212 · Cited by 722
Halliwell, B., Rafter, J., & Jenner, A. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.268s · Cited by 711 · cited 3×
“…polyphenols in animal and human subjects, including decreased LDL and DNA oxidation and increased plasma total antioxidant potential, were evaluated using fruit juices, soy or vegetables, it was found that the observed beneficial effect might not be attributed to polyphenols (Halliwell et al., 2005).”
BackgroundInteraction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review
Duda-Chodak, A., Tarko, T., Satora, P., & Sroka, P. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0852-y · Cited by 599 · cited 4×
“Ring-C cleavage of anthocyanins produces many phenolic acids such protocatechuic (PCA), gallic, 3-O-methyl-gallic, syringic, p-coumaric, and vanillic acids, as well as 2,4,6-trihydroxybenzaldehyde (Duda-Chodak et al., 2015).”
BackgroundInfluentialHopkins, M. J., Sharp, R., & Macfarlane, G. T. (2001) · Gut · doi:10.1136/gut.48.2.198 · Cited by 577 · cited 2×
“Many species of Enterobacteriaceae are a normal part of the gut flora found in the intestines of humans with their intensity increasing with age (Hopkins et al., 2001).”
BackgroundCarbohydrate terminology and classification
Cummings, J. H., & Stephen, A. M. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602936 · Cited by 570
Diversity of the human gastrointestinal tract microbiota revisited
Rajilić‐Stojanović, M., Smidt, H., & De Vos, W. M. (2007) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01369.x · Cited by 559 · cited 3×
“%) come from 50 to 60 species (Guarner and Malagelada, 2003; Rajilic-Stojanovic et al., 2007).”
BackgroundGenomic and metabolic adaptations of Methanobrevibacter smithii to the human gut
Samuel, B. S., Hansen, E. E., Manchester, J. K., Coutinho, P. M., Henrissat, B., Fulton, R., Latreille, P., Kim, K., Wilson, R. K., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704189104 · Cited by 549
THE MICROBIAL CONTRIBUTION TO HUMAN FAECAL MASS
Stephen, A. M., & Cummings, J. H. (1980) · Journal of Medical Microbiology · doi:10.1099/00222615-13-1-45 · Cited by 545 · cited 1×
“Because of their abundance in the intestine, bacteria represents ∼ 60% of fecal dry mass (Stephen and Cummings, 1980).”
BackgroundGanesh, B. P., Klopfleisch, R., Loh, G., & Blaut, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074963 · Cited by 522 · cited 1×
“…for example a Chinese MGWAS study stated that A . muciniphila did not improve mucous layer thickness (Tilg and Moschen, 2014), while Ganesh et al. attributed exacerbated inflammation in Salmonella typhimurium -infected mice to the mucin-degrading effect of A. muciniphila (Ganesh et al., 2013).”
BackgroundThe gut microbiota in human energy homeostasis and obesity
Rosenbaum, M., Knight, R., & Leibel, R. L. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.002 · Cited by 450 · cited 3×
“Short-chain fatty acids (SCFA) produced from indigestible carbohydrates by gut microbes are used as energy by various human tissues (Rosenbaum et al., 2015).”
BackgroundEtxeberria, U., Arias, N., Boqué, N., Macarulla, M. T., Portillo, M. P., Martínez, J. A., & Milagro, F. I. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.01.002 · Cited by 446 · cited 3×
“Moreover, it decreased the abundance of bacteria associated with diet-induced obesity, such as Bacillus spp., Eubacterium cylindroide, and Erysipelotrichaceae (Etxeberria et al., 2015) and increased the growth of Bifidobacterium and Lactobacillus (Qiao et al., 2014; Etxeberria et al., 2015).”
BackgroundArchaea and the Human Gut: New Beginning of an Old Story
Gaci, N., Borrel, G., Tottey, W., O’Toole, P. W., & Brugère, J.-F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i43.16062 · Cited by 422 · cited 2×
“Such changes in densities explain the absence of methane gas, as detected by a breath test, during infancy in contrast to adulthood (Gaci et al., 2014).”
BackgroundSong, Y., Manson, J. E., Buring, J. E., Sesso, H. D., & Liu, S. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719488 · Cited by 389 · cited 1×
“Similar negative results were reported from other cross-sectional studies attempting to relate protection against diabetes to the intake of total flavonols and flavones (Song et al., 2005) or anthocyanins in the Iowa women (Nettleton et al., 2006).”
ResultQiao, Y., Sun, J., Xia, S., Tang, X., Shi, Y., & Le, G. (2014) · Food & Function · doi:10.1039/c3fo60630a · Cited by 367 · cited 10×
“Interestingly, incubation of anthocyanins with fecal bacteria in stirred, batch-culture fermentation vessels simulating human colon conditions resulted in an increase of the beneficial Bifidobacterium spp. and Lactobacillus-Enterococcus spp. levels (Hidalgo et al., 2012).”
BackgroundInfluentialMucosal Prevalence and Interactions with the Epithelium Indicate Commensalism of Sutterella spp.
Hiippala, K., Kainulainen, V., Kalliomäki, M., Arkkila, P., & Satokari, R. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01706 · Cited by 351 · cited 2×
“They have received much attention in recent year because their density is reported to increase in inflammatory bowel diseases and in children suffering from autism and down-syndrome (De Angelis et al., 2013; Hiippala et al., 2016).”
BackgroundMorotomi, M., Nagai, F., & Watanabe, Y. (2012) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.026989-0 · Cited by 297 · cited 1×
“…species with few exceptions such as Faecalibacterium prausnitzii (Duncan et al., 2002) previously known as Fusobacterium prausnitzii in the phylum Fusobacteria, and Christensenella minuta (Morotomi et al., 2012), C. massiliensis (Ndongo et al., 2016b), and C. timonensis (Ndongo et al., 2016a).”
BackgroundRegulation of Glucose Homeostasis by GLP-1
Nadkarni, P., Chepurny, O. G., & Holz, G. G. (2014) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-800101-1.00002-8 · Cited by 287 · cited 1×
“GLP-1 stimulates the release of insulin, suppresses the release of glucagon (Nadkarni et al., 2014), lowers the blood glucose (Nauck et al., 1993), and plays a major role in glucose homeostasis (Kieffer and Habener, 1999; Deacon, 2004).”
BackgroundPace, N. R. (2006) · Nature · doi:10.1038/441289a · Cited by 276
Freeland, K. R., & Wolever, T. M. S. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509991863 · Cited by 275
Hooda, S., Boler, B. M. V., Serao, M. C. R., Brulc, J. M., Staeger, M. A., Boileau, T. W., Dowd, S. E., Fahey, G. C., & Swanson, K. S. (2012) · The Journal of Nutrition · doi:10.3945/jn.112.158766 · Cited by 272
Role of resistant starch in improving gut health, adiposity, and insulin resistance
Keenan, M. J., Zhou, J., Hegsted, M., Pelkman, C., Durham, H. A., Coulon, D. B., & Martin, R. J. (2015) · Advances in Nutrition · doi:10.3945/an.114.007419 · Cited by 243
Shrime, M. G., Bauer, S. R., McDonald, A. C., Chowdhury, N. H., Coltart, C. E. M., & Ding, E. L. (2011) · The Journal of Nutrition · doi:10.3945/jn.111.145482 · Cited by 234 · cited 1×
“A meta-analysis of 24 randomized clinical trials (RCTs) has documented the improvement of insulin resistance after daily consumption of flavonoid-rich cocoa beverages (Shrime et al., 2011; Ellinger and Stehle, 2016).”
BackgroundGondalia, S. V., Palombo, E. A., Knowles, S. R., Cox, S. B., Meyer, D., & Austin, D. W. (2012) · Autism Research · doi:10.1002/aur.1253 · Cited by 208 · cited 1×
“…microbiota ( Figure 1 ), the factors altering this composition, and relating it to the pathogenesis of some diseases such as diabetes (Yamaguchi et al., 2016), autism (Berding and Donovan, 2016), obesity (Valsecchi et al., 2016), and other disorders (Gondalia et al., 2012; Baothman et al., 2016).”
BackgroundShort-Chain Fatty Acid Receptor and Its Contribution to Glucagon-Like Peptide-1 Release
Kaji, I., Karaki, S.-I., & Kuwahara, A. (2014) · Digestion · doi:10.1159/000356211 · Cited by 177 · cited 1×
“FFAR2 is activated by acetate and propionate, while FFAR3 is activated by propionate and butyrate (Kaji et al., 2014).”
BackgroundEdholm, T., Degerblad, M., Grybäck, P., Hilsted, L., Holst, J. J., Jacobsson, H., Efendic, S., Schmidt, P. T., & Hellström, P. M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01554.x · Cited by 164 · cited 9×
“Oligo-and poly-saccharides such as fructo-oligosaccharides (FOS), Glucooligosaccharides (GOS), oligofructoses (OFS), inulin-type fructans (ITF), fructans, Arabinoxylooligosaccharides (AXOS), resistant maltodextrin, resistant starch, and guar gum increase GLP-1 (Wang X. et al., 2015).”
BackgroundInfluentialProbiotics as Complementary Treatment for Metabolic Disorders
Le Barz, M., Anhê, F. F., Varin, T. V., Desjardins, Y., Levy, E., Roy, D., Urdaci, M. C., & Marette, A. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.291 · Cited by 142
Gut microbiota modulate the metabolism of brown adipose tissue in mice
Mestdagh, R., Dumas, M.-E., Rezzi, S., Kochhar, S., Holmes, E., Claus, S. P., & Nicholson, J. K. (2012) · Journal of Proteome Research · doi:10.1021/pr200938v · Cited by 97 · cited 1×
“Gut microbiota modulates the brown adipose tissues (BATs) (Mestdagh et al., 2012).”
BackgroundThe role of peptide YY in regulating glucose homeostasis
Boey, D., Sainsbury, A., & Herzog, H. (2007) · Peptides · doi:10.1016/j.peptides.2006.07.031 · Cited by 77
Evaluation of prebiotic effects of high-purity galactooligosaccharides in vitro and in vivo
Department of Public Health Sciences, G. S., Hong, K. B., Kim, J. H., Neo Cremar Co. Ltd., S. 4.-8., Kwon, H. K., Neo Cremar Co. Ltd., S. 4.-8., Han, S. H., Institute for Biomaterials, K. U., Park, Y., Institute for Biomaterials, K. U., et al. (2016) · Food Technology and Biotechnology · doi:10.17113/ftb.54.02.16.4292 · Cited by 45
Cited by
Natural products in drug discovery: advances and opportunities
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Taskforce, T. I. N. P. S., Orhan, I. E., Banach, M., Rollinger, J. M., Barreca, D., Weckwerth, W., Bauer, R., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00114-z · Cited by 5,392
Self-citationCorrêa, T. A. F., Rogero, M. M., Hassimotto, N. M. A., & Lajolo, F. M. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00188 · Cited by 316
Zhao, C., Yang, C., Wai, S. T. C., Zhang, Y., P. Portillo, M., Paoli, P., Wu, Y., San Cheang, W., Liu, B., Carpéné, C., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1501658 · Cited by 199
Yacoub, R., Nugent, M., Cai, W., Nadkarni, G. N., Chaves, L. D., Abyad, S., Honan, A. M., Thomas, S. A., Zheng, W., Valiyaparambil, S. A., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184789 · Cited by 139
Links between Dietary Protein Sources, the Gut Microbiota, and Obesity
Madsen, L., Myrmel, L. S., Fjære, E., Liaset, B., & Kristiansen, K. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.01047 · Cited by 110
Metadata
- Authors
- Eid, H. M., Wright, M. L., Anil Kumar, N. V., Qawasmeh, A., Hassan, S. T. S., Mocan, A., Nabavi, S. M., Rastrelli, L., Atanasov, A. G., & Haddad, P. S.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-06-30
- Volume
- 8
- Pages
- 387-387
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2717418392
- Cited by
- 103
- References
- 76
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.